Idioma:

Antimicrobial Activity of the Pleuromutilin Antibiotic BC-3781 against Bacterial Pathogens Isolated in the SENTRY Antimicrobial Surveillance Program in 2010

PAUKNER, Susanne ; SADER, Helio S ; IVEZIC-SCHOENFELD, Zrinka ; JONES, Ronald N

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4489-4495 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por

Enviar para

Título:
Antimicrobial Activity of the Pleuromutilin Antibiotic BC-3781 against Bacterial Pathogens Isolated in the SENTRY Antimicrobial Surveillance Program in 2010
Autor: PAUKNER, Susanne ; SADER, Helio S ; IVEZIC-SCHOENFELD, Zrinka ; JONES, Ronald N
Assuntos: Anti-Bacterial Agents ; Anti-Bacterial Agents - pharmacology ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Community-Acquired Infections ; Community-Acquired Infections - drug therapy ; Community-Acquired Infections - microbiology ; Diterpenes - pharmacology ; Enterococcus faecium ; Enterococcus faecium - drug effects ; Enterococcus faecium - growth & development ; Epidemiological Monitoring ; Epidemiology and Surveillance ; Haemophilus influenzae ; Haemophilus influenzae - drug effects ; Haemophilus influenzae - growth & development ; Humans ; Medical sciences ; Methicillin-Resistant Staphylococcus aureus ; Methicillin-Resistant Staphylococcus aureus - drug effects ; Methicillin-Resistant Staphylococcus aureus - growth & development ; Methicillin-Resistant Staphylococcus aureus - isolation & purification ; Microbial Sensitivity Tests ; Moraxella catarrhalis ; Moraxella catarrhalis - drug effects ; Moraxella catarrhalis - growth & development ; Pharmacology. Drug treatments ; Pleuromutilins ; Pneumonia, Bacterial ; Pneumonia, Bacterial - drug therapy ; Pneumonia, Bacterial - microbiology ; Polycyclic Compounds ; Staphylococcal Skin Infections ; Staphylococcal Skin Infections - drug therapy ; Staphylococcal Skin Infections - microbiology ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - growth & development ; Staphylococcus aureus - isolation & purification ; Streptococcus pneumoniae ; Streptococcus pneumoniae - drug effects ; Streptococcus pneumoniae - growth & development ; Vancomycin Resistance - drug effects
É parte de: Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4489-4495
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Descrição: Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC
Editor: Washington, DC: American Society for Microbiology
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Antimicrobial Activity of the Pleuromutilin Antibiotic BC-3781 against Bacterial Pathogens Isolated in the SENTRY Antimicrobial Surveillance Program in 2010

PAUKNER, Susanne ; SADER, Helio S ; IVEZIC-SCHOENFELD, Zrinka ; JONES, Ronald N

Washington, DC: American Society for Microbiology

Buscando em bases de dados remotas. Favor aguardar.